Sequrna
Company Details
Status: Private
Employees: 1-10
Location:
Stockholm, Sweden
Type:
sample
sample
Technology:
sample
sample
About: Introducing next-generation RNase inhibitors - ideal for single-cell and in situ RNA-sequencing
SEQURNA's RNase inhibitor makes RNA work and sequencing pipelines more accessible, affordable, and sustainable. Unlike competitors’ recombinant RNase inhibitors, the SEQURNA inhibitor is thermostable and can be shipped and stored at room temperature without affecting performance. These features do not only simplify shipping and storage logistics, eliminate batch effects, and reduce costs for the user – but also enable new and simplified workflows as well as novel laboratory protocols including heat cycles.
Propel your biotech business or research, and choose a more environmentally sustainable option for RNase inhibition in your RNA-seq workflows, by becoming an early user of SEQURNA’s RNase inhibitor. Our R&D team is keen to assist and advice in the transition.
Find out more at www.sequrna.com or email us at info@sequrna.com
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Sequrna | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.